Target intelligence / Profile preview

Connexin 43 - Zonula occludens-1 interaction (null)

Target
null
Molecular classification
Gap junction protein (Connexin 43 is classified as an ion channel protein), Tight junction scaffold protein (Zonula occludens-1 is classified as a tight junction scaffold/adaptor)
01

Overview

The Connexin 43 - Zonula occludens-1 interaction constitutes a critical regulatory interface for gap junction formation, size, and cell-cell communication. Connexin 43 (Cx43) forms intercellular channels that assemble into gap junctions, crucial for ionic and molecular exchange in tissues. Zonula occludens-1 (ZO-1), a scaffold tight junction protein, binds specifically to the carboxy terminus of Cx43 via a PDZ domain interaction, mostly at the periphery of gap junction plaques. This interaction controls the recruitment and turnover of connexons (hemichannels) into gap junctions; when ZO-1 binding to Cx43 is inhibited, gap junctions enlarge, increasing intercellular coupling but altering cellular permeability and organization. Regulation of this interface is important in excitable tissues such as the heart and brain, influencing disease states when dysregulated[1][2][3][4].

Other names
Connexin43-ZO-1 interactionCx43-ZO-1 interfaceCx43-TJP1 interaction (TJP1 is the gene for ZO-1)
02

Mechanism of action

Disruption of Cx43-ZO-1 binding increases gap junction plaque size and enhances intercellular communication, while decreasing hemichannel activity in contacting cells

03

Biological functions

Cell-cell communicationRegulation of gap junction size and turnoverDynamic partitioning of channel function between junctional and non-junctional plasma membrane domainsModulation of actin cytoskeleton anchoring
04

Disease associations

Cardiovascular disease (altered gap junction function is implicated)Neurodegenerative disease (gap junction dysregulation is relevant to brain tissue)Other (general tissue development and wound healing)
05

Safety considerations

Therapeutic modulation of gap junctions may alter cardiac conduction or neurologic functionExcessive gap junction activity could affect tissue homeostasis and cell viability
06

Interacting drugs

Peptides mimicking the Cx43 PDZ-binding domain, e.g. αCT-1 peptide, which is used experimentally to inhibit the Cx43-ZO-1 interaction
07

Biomarkers

Levels/distribution of Connexin 43 and/or ZO-1 in tissue can be used to monitor gap junction integrity

Beyond the preview

Go deeper on Connexin 43 - Zonula occludens-1 interaction (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Connexin 43 - Zonula occludens-1 interaction (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call